OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone
Marjorie R. Levinstein, Paulo Alexandre de Oliveira, Nil Casajuana‐Martin, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 3, pp. 624-632
Open Access | Times Cited: 8
Marjorie R. Levinstein, Paulo Alexandre de Oliveira, Nil Casajuana‐Martin, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 3, pp. 624-632
Open Access | Times Cited: 8
Showing 8 citing articles:
Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?
Marjorie R. Levinstein, Reece C. Budinich, Jordi Bonaventura, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 2
Marjorie R. Levinstein, Reece C. Budinich, Jordi Bonaventura, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 2
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 6
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 6
Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone’
M. Pappagallo, Thomas R. Kosten, Charles W. Gorodetzky, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3935-3937
Open Access | Times Cited: 4
M. Pappagallo, Thomas R. Kosten, Charles W. Gorodetzky, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3935-3937
Open Access | Times Cited: 4
Neural circuit-selective, multiplexed pharmacological targeting of prefrontal cortex-projecting locus coeruleus neurons drives antinociception
Chao‐Cheng Kuo, Jordan G. McCall
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Chao‐Cheng Kuo, Jordan G. McCall
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (R)- and (S)-Methadone Metabolites as N-Methyl-d -aspartate Receptor Antagonists
Marco Banzato, Alberto Furlan, Patrizia Locatelli, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Marco Banzato, Alberto Furlan, Patrizia Locatelli, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Subcutaneous methadone is not different than transdermal fentanyl for postoperative analgesia in dogs with thoracolumbar disc disease, using three different pain scales and von Frey Filaments, a prospective, randomised, blinded clinical study
Alexandra F. Schütter, Anika Verhoeven, Julia Tünsmeier, et al.
Research Square (Research Square) (2025)
Closed Access
Alexandra F. Schütter, Anika Verhoeven, Julia Tünsmeier, et al.
Research Square (Research Square) (2025)
Closed Access
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
Megan J. Shram, Jack E. Henningfield, Glen Apseloff, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Megan J. Shram, Jack E. Henningfield, Glen Apseloff, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”
Marjorie R. Levinstein, Paulo Alexandre de Oliveira, Nil Casajuana‐Martin, et al.
Molecular Psychiatry (2024)
Closed Access
Marjorie R. Levinstein, Paulo Alexandre de Oliveira, Nil Casajuana‐Martin, et al.
Molecular Psychiatry (2024)
Closed Access
